4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-049567
Chief Medical Officer sold 12,425 shares at $3.47 ($43,082)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bedrosian Camille L Chief Medical Officer | 2025-03-31 | Sale | −12,425 | $3.47 | $43,082 | 194,375 | D |
| Open-market sales · 12,425 sh · avg $3.47 · $43,082 | |||||||
Loading xslF345X05/ownership.xml…